Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia clinical trial (NCT01381094). Contact the study team or your healthcare provider for specific answers.

Question 2

How does AKB-6548 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia clinical trial (NCT01381094). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia clinical trial (NCT01381094). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia clinical trial (NCT01381094). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia clinical trial (NCT01381094). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my health be monitored closely during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia clinical trial (NCT01381094). Contact the study team or your healthcare provider for specific answers.

What this study is about